Paolo Samutprakarn Company Limited, commonly referred to as Paolo Healthcare, is a leading healthcare provider headquartered in Samut Prakan, Thailand. Established in 1994, the company has grown to become a prominent player in the healthcare industry, operating multiple hospitals and clinics across the region. Specialising in a wide range of medical services, Paolo Healthcare is renowned for its commitment to quality patient care and innovative healthcare solutions. The company offers unique services, including advanced diagnostic imaging and specialised surgical procedures, setting it apart from competitors. With a strong market position, Paolo Healthcare has achieved numerous accolades for excellence in healthcare delivery, making it a trusted name in the Thai healthcare landscape. Its dedication to improving health outcomes continues to drive its success and expansion in the industry.
How does Paolo Samutprakarn Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Paolo Samutprakarn Company Limited's score of 37 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Paolo Samutprakarn Company Limited, headquartered in Thailand, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bangkok Dusit Medical Services Public Company Limited, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Paolo Samutprakarn Company Limited. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. Given its affiliation with Bangkok Dusit Medical Services Public Company Limited, it is important to note that any climate-related initiatives or performance metrics may be inherited from this parent organisation. However, without explicit data or targets from Paolo Samutprakarn Company Limited, it is challenging to provide a detailed overview of its carbon emissions and climate commitments. In summary, while Paolo Samutprakarn Company Limited is part of a larger corporate family that may have established climate initiatives, specific emissions data and reduction commitments for the company itself remain unavailable.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,751,980 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 96,755,960 | 000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 |
Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Paolo Samutprakarn Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.